Grace Therapeutics (GRCE) Invested Capital (2017 - 2019)
Grace Therapeutics (GRCE) posted Invested Capital of $14.0 million for Q1 2019, up 96.11% sequentially from $7.1 million in Q1 2018, and up 96.11% YoY from $7.1 million in Q1 2018.
Grace Therapeutics (GRCE) Invested Capital (2017 - 2019) Analysis & Trends
Grace Therapeutics has reported Invested Capital for 3 years, with the latest figure at $14.0 million in Q1 2019.
- Quarterly Invested Capital rose 96.11% year-over-year to $14.0 million in Q1 2019, while the trailing twelve-month figure through Dec 2019 was $14.0 million (changed N/A YoY) and the FY2019 annual result came in at $14.0 million, up 96.11% from the prior year.
- Invested Capital advanced to $14.0 million in Q1 2019 per GRCE's latest filing, from $7.1 million in the prior quarter.
- Over five years, Invested Capital peaked at $14.0 million in Q1 2019 and troughed at $2.9 million in Q1 2017.
- A 3-year average of $8.0 million and a median of $7.1 million in 2018 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 96.11% in 2019, down 96.11% in 2019.
- Over 3 years, Invested Capital stood at $2.9 million in 2017, then surged by 148.43% to $7.1 million in 2018, then jumped by 96.11% to $14.0 million in 2019.
- According to Business Quant data, Invested Capital over the past three periods registered $14.0 million, $7.1 million, and $2.9 million for Q1 2019, Q1 2018, and Q1 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Grace Therapeutics | 37.99 Mn | 37.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 13.97 Mn |
| Mar 31, 2018 | 7.12 Mn |
| Feb 28, 2017 | 2.87 Mn |